# Peruvian Chanchamayo (Coffea arabica) **Canonical URL:** https://ingredients.hermeticasuperfoods.com/ingredients/peruvian-chanchamayo **Data Source:** Hermetica Superfoods Ingredient Encyclopedia **Updated:** 2026-04-01 **Evidence Score:** 2 / 10 **Category:** Coffee Cultivars **Also Known As:** Chanchamayo coffee, Chanchamayo Valley coffee, Peruvian Chanchamayo arabica, Junin Chanchamayo coffee, Chanchamayo beans ## Overview Peruvian Chanchamayo is a high-altitude Coffea arabica cultivar grown in Peru's Junín region, valued primarily for its cup quality rather than distinct clinical properties. Its bioactive profile mirrors standard Coffea arabica, featuring caffeine and chlorogenic acids as the primary pharmacologically active compounds. ## Health Benefits • No clinical health benefits established - no clinical trials, RCTs, or meta-analyses specific to Peruvian Chanchamayo were identified • General Coffea arabica research exists but does not differentiate this cultivar variant • No biomedical evidence for unique health properties beyond standard coffee • No data on bioactive compounds specific to this variant • Currently documented only as a specialty beverage coffee, not a therapeutic ingredient ## Mechanism of Action Caffeine, the primary alkaloid in Chanchamayo coffee, acts as a competitive antagonist at adenosine A1 and A2A receptors, reducing neural inhibition and increasing [dopamine](/ingredients/condition/mood)rgic and noradrenergic tone. Chlorogenic acids, including 5-caffeoylquinic acid, inhibit glucose-6-phosphatase activity and modulate AMPK signaling pathways, contributing to modest [glucose metabolism](/ingredients/condition/weight-management) effects observed in general Coffea arabica research. These compounds also exert antioxidant activity by scavenging [reactive oxygen species](/ingredients/condition/antioxidant) and upregulating Nrf2-mediated endogenous antioxidant defenses. ## Clinical Summary No clinical trials, randomized controlled trials, or meta-analyses have been conducted specifically on Peruvian Chanchamayo coffee as a distinct cultivar. Existing clinical evidence is derived from broader Coffea arabica research, including large cohort studies such as the EPIC study involving over 500,000 participants, which associated habitual coffee consumption with reduced risk of type 2 diabetes and liver disease. These associations cannot be directly attributed to Chanchamayo specifically, as cultivar-level differentiation is absent from published biomedical literature. The evidence base for this specific origin coffee remains at the level of general arabica research, making any cultivar-specific health claims unsupported. ## Nutritional Profile Based on standard Coffea arabica green bean composition (no Chanchamayo-specific analytical data available): Macronutrients per 100g green bean — Carbohydrates: 47-55g (primarily sucrose 6-9g, polysaccharides 35-40g); Protein: 10-13g (includes free amino acids ~0.5g, with glutamic acid, aspartic acid, and alanine predominating); Lipids: 12-18g (arabica characteristically higher fat than robusta; lipid fraction includes diterpenes cafestol and kahweol at ~0.5-1.0g/100g — these are largely retained in unfiltered brews and are absent or minimal in paper-filtered coffee). Moisture in green bean: ~10-12%. Per 240ml brewed cup (standard drip): Calories: 2-5 kcal; Caffeine: 80-120mg (arabica typically lower than robusta; Chanchamayo altitude ~1500-2000m MASL may influence caffeine concentration, though no cultivar-specific data confirmed); Chlorogenic acids (primary bioactive): 70-350mg per cup (5-CQA, 3-CQA, 4-CQA isomers dominant); Trigonelline: 60-100mg per cup (degrades to niacin upon roasting, yielding ~1-3mg niacin equivalent); Kahweol and cafestol: negligible in filtered brew, 2-4mg each per espresso shot. Micronutrients per brewed cup: Potassium: 116mg; Magnesium: 7mg; Niacin (B3): 0.5mg; Riboflavin (B2): 0.2mg; Manganese: 0.1mg; Phosphorus: 7mg. Bioavailability notes: Chlorogenic acids have moderate bioavailability (~30% absorbed in small intestine); colonic microbiota further metabolize remaining fraction to caffeic and ferulic acid derivatives. Caffeine bioavailability is high (~99%). Diterpenes bioavailability is brew-method dependent — near zero in paper-filtered drip, significant in French press or espresso. High-altitude Chanchamayo origin (Junín region) is associated with slower bean maturation, potentially yielding higher sucrose and organic acid content (malic, citric, quinic acids ~7-10g/kg green bean) compared to lower-altitude arabica, but this is an agronomic inference not confirmed by published assay data specific to this origin. ## Dosage & Preparation No clinically studied dosage ranges for Peruvian Chanchamayo in extract, powder, or standardized forms were found, as it lacks biomedical clinical data. The product is documented solely as whole beans for beverage brewing. Consult a healthcare provider before starting any new supplement. ## Safety & Drug Interactions As a Coffea arabica product, Peruvian Chanchamayo carries the same safety profile as standard coffee, with caffeine intake above 400 mg per day associated with anxiety, [insomnia](/ingredients/condition/sleep), tachycardia, and elevated [blood pressure](/ingredients/condition/heart-health) in sensitive individuals. Caffeine is a known inhibitor of CYP1A2 and interacts with adenosine-based medications, anticoagulants like warfarin, and stimulant drugs including pseudoephedrine, potentially amplifying cardiovascular side effects. Pregnant individuals are advised to limit caffeine to under 200 mg per day due to associations with low birth weight and preterm delivery in observational data. Individuals with arrhythmias, GERD, or anxiety disorders should exercise caution with regular high-dose consumption. ## Scientific Research No clinical trials, RCTs, or meta-analyses specific to Peruvian Chanchamayo (Coffea arabica) were identified in the available sources. While general coffee (Coffea arabica) research exists on PubMed (e.g., PMID 28628481 for meta-analysis on coffee and [cardiovascular risk](/ingredients/condition/heart-health); PMID 34589048 for RCTs on caffeine effects), none differentiate this cultivar variant or its unique profile. ## Historical & Cultural Context No evidence of historical or traditional medicinal use for Peruvian Chanchamayo was identified. It is documented solely as a specialty coffee cultivar for beverage consumption, with production emphasizing fair-trade and organic practices since the rise of cooperatives. ## Synergistic Combinations Not applicable - no biomedical synergies established ## Frequently Asked Questions ### What makes Peruvian Chanchamayo coffee different from other Coffea arabica varieties? Peruvian Chanchamayo is distinguished primarily by its geographic origin in the Chanchamayo valley of Junín, Peru, grown at elevations between 1,000 and 2,000 meters above sea level. This altitude influences the density of chlorogenic acid and caffeine concentrations due to slower bean maturation, but no peer-reviewed study has formally quantified whether its phytochemical profile is statistically distinct from other arabica origins. ### Does Peruvian Chanchamayo coffee have proven health benefits? No clinical trials have been conducted specifically on Peruvian Chanchamayo coffee, so no cultivar-specific health benefits are clinically established. General Coffea arabica research associates regular coffee consumption with reduced risk of type 2 diabetes, Parkinson's disease, and liver cirrhosis, but these findings cannot be exclusively attributed to this particular cultivar. ### How much caffeine does Peruvian Chanchamayo coffee contain? As a Coffea arabica variety, Chanchamayo typically contains approximately 1.2–1.5% caffeine by dry weight in the green bean, yielding roughly 80–120 mg of caffeine per standard 8 oz brewed cup depending on roast level and brew method. Lighter roasts preserve slightly more caffeine by mass, though the difference between roast profiles is modest. ### Is Peruvian Chanchamayo coffee safe during pregnancy? Like all caffeinated coffee, Peruvian Chanchamayo should be consumed with caution during pregnancy. Major health bodies including the WHO and ACOG recommend limiting total caffeine intake to under 200 mg per day during pregnancy, as higher intakes have been associated in meta-analyses with increased risk of low birth weight and spontaneous miscarriage. ### Can Peruvian Chanchamayo coffee interact with medications? Caffeine present in Chanchamayo coffee inhibits the cytochrome P450 enzyme CYP1A2, which can slow the metabolism of drugs such as clozapine, theophylline, and certain antidepressants, raising their plasma concentrations. Additionally, caffeine may potentiate stimulant medications and reduce the efficacy of adenosine used in cardiac stress testing, requiring patients to abstain from coffee 24 hours before such procedures. ### What is the origin and growing region of Peruvian Chanchamayo coffee? Peruvian Chanchamayo coffee is grown in the Chanchamayo region of the Junín Province in central Peru, an area known for its high altitude and favorable climate conditions. This geographic region produces a specialty-grade arabica cultivar recognized for its distinct sensory profile. The specific terroir and cultivation practices in this region contribute to its classification as a premium coffee variant, though these characteristics are primarily organoleptic rather than biochemically unique compared to other arabica coffees. ### How does Peruvian Chanchamayo coffee compare in caffeine content to other arabica coffee origins? Peruvian Chanchamayo coffee contains caffeine consistent with standard Coffea arabica varieties, typically ranging from 1.2–1.5% by dry weight. Caffeine content in coffee is determined primarily by the arabica species itself rather than by specific cultivar variant or geographic origin, meaning Chanchamayo coffee does not differ meaningfully from other arabica coffees in caffeine levels. Factors like roast level and brewing method have more influence on the final caffeine concentration in your cup than the coffee's regional origin. ### What makes Peruvian Chanchamayo coffee classified as a specialty or premium coffee? Peruvian Chanchamayo coffee achieves specialty-grade status based on sensory evaluation, cup profile, and quality scoring rather than unique health or biochemical properties. Specialty designation reflects factors such as flavor complexity, acidity balance, and absence of defects—characteristics assessed by professional cupping standards. This classification is distinct from health or nutritional superiority; Chanchamayo's premium status is rooted in taste profile and production quality, not in clinically differentiated bioactive compounds or health benefits. --- *Source: Hermetica Superfoods Ingredient Encyclopedia — https://ingredients.hermeticasuperfoods.com* *License: CC BY-NC-SA 4.0 — Attribution required. Commercial use: admin@hermeticasuperfoods.com*